Investigation of the economic impact of surgical site infection development in cardiovascular surgeries on the prospective payment system in Japan
AbstractThe purpose of this study was to evaluate the economic burden of surgical site infections (SSIs) that are included in the category of clean operation in the field of cardiovascular surgery. In total, 2,583 patients who underwent cardiac surgeries at Juntendo University Hospital in Japan between April 2008 and March 2018 were investigated. Among them, 9 SSI cases were individually matched to non-SSI cases based on a combination of age group (in 5-year increments), gender, timing of hospitalization (in 2-year intervals), National Healthcare Safety Network (NHSN) Risk Index, main disease category, and length of stay (LOS) prior to surgery (with the difference of ≤2 days). SSI and non-SSI cases were compared in terms of median LOS and piecework reference cost (PRC). The median LOS was 30 days for SSI cases and 19 days for non-SSI cases (p<0.05). The median PRC was 1,257,630 Japanese Yen [JPY] for SSI cases and 884,720 JPY for non-SSI cases (p<0.05). This study demonstrated that the development of SSIs significantly extended LOS and increased excess treatment costs. However, since the current Japanese prospective payment system, the Diagnosis Procedure Combination (DPC)-based payment system is calculated on daily basis, it was suggested that in some cases it may be more beneficial to keep a certain LOS than to inhibit SSI episodes with an aim to shorten LOS. It was also found that in hospitals with relatively shorter LOS, deemed benefit may be reduced in certain diagnosis-related groups. This may result in discouraging the prevention of SSIs.
Copyright conditions: Copyright on any research article in the International Journal of Infection Control (IJIC) is retained by the author(s). Authors grant IJIC permission to publish the article and identify itself as the original publisher. Authors also grant any third party the right to use the article freely as long as its integrity is maintained and its original authors, citation details and publisher are identified. IJIC conforms to the Creative Commons Attribution License (http://creativecommons.org) as terms and conditions of publishing research articles. In summary, anyone is free: • to copy, distribute, and display the work; • to make derivative works; • to make commercial use of the work; as long as: • the original author must be given credit; • for any reuse or distribution, it must be made clear to others what the license terms of this work are; • any of these conditions can be waived if the authors gives permission. Statutory fair use and other rights are in no way affected by the above. Authors' certification: In submitting a manuscript to IJIC, authors are requested to certify that: • They are authorized by their co-authors to enter into these arrangements. • They warrant, on behalf of themselves and their co-authors, that: o the article is original, has not been formally published in any other peer-reviewed journal, is not under consideration by any other journal and does not infringe any existing copyright or any other third party rights; o they are the sole author(s) of the article and have full authority to enter into this agreement and in granting rights to IJIC are not in breach of any other obligation. If the law requires that the article be published in the public domain, they will notify IJIC at the time of submission; o the article contains nothing that is unlawful, libellous, or which would, if published, constitute a breach of contract or of confidence or of commitment given to secrecy; o they have taken due care to ensure the integrity of the article.